Amgen Stock Slumps Amid Broader Market Pressures
Amgen Inc.'s (NASDAQ: AMGN) stock took a hit today, closing down 1.10% as investor sentiment waned amidst broader market pressures.
The biotech giant's shares slipped to CA$378.26, marking a significant shift in the company's performance over the past month, which has seen a 5.99% decline underperforming its sector and the broader market.
Investors are advised to closely monitor Amgen's upcoming earnings report as market sentiment shifts and competition intensifies within the biotech space.